Forbes listed ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) as the best performing biotechnology stock over the past 52 weeks lifting the stock price $1.06 to close at $13.15.
ACADIA Listed As Best Performing Biotech
April 22, 2013 at 18:56 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
| ||||||